As Russia’s Sputnik V vaccine undergoes its third phase of clinical trials, with over 40,000 participants expected to take part, Western countries and media outlets have scoffed at its early approval. This comes as no surprise…
Media slams Sputnik V but stays silent as Western pharma chases approval for its jabs
